Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis
NCT02818543
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Interventions
DRUG:
LYC-30937
Sponsor
Lycera Corp.